6U7X

NMR solution structure of triazole bridged plasmin inhibitor

6U7X の概要

• エントリーDOI: 10.2210/pdb6u7x/pdb
• 関連するPDBエントリー: 6Q1U 6U22 6U24 6U7Q 6U7R 6U7S 6U7U 6U7W
• NMR情報: BMRB: 30671
• 分子名称: GLY-ARG-ALA-TYR-LYS-SER-LYS-PRO-PRO-ILE-ALA-PHE-PRO-ASP, 1-methyl-1H-1,2,3-triazole (2 entities in total)
• 機能のキーワード: triazole, disulfide mimetic, inhibitor, biosynthetic protein
• 由来する生物種: Helianthus annuus
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 1632.88

構造登録者

White, A.M.,Harvey, P.J.,Wang, C.K.,Durek, T.,Craik, D.J. (登録日: 2019-09-03, 公開日: 2020-04-22, 最終更新日: 2024-10-30)

主引用文献

White, A.M.,de Veer, S.J.,Wu, G.,Harvey, P.J.,Yap, K.,King, G.J.,Swedberg, J.E.,Wang, C.K.,Law, R.H.P.,Durek, T.,Craik, D.J.
Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides.
Angew.Chem.Int.Ed.Engl., 59:11273-11277, 2020

PubMed Abstract: Ruthenium-catalysed azide-alkyne cycloaddition (RuAAC) provides access to 1,5-disubstituted 1,2,3-triazole motifs in peptide engineering applications. However, investigation of this motif as a disulfide mimetic in cyclic peptides has been limited, and the structural consequences remain to be studied. We report synthetic strategies to install various triazole linkages into cyclic peptides through backbone cyclisation and RuAAC cross-linking reactions. These linkages were evaluated in four serine protease inhibitors based on sunflower trypsin inhibitor-1. NMR and X-ray crystallography revealed exceptional consensus of bridging distance and backbone conformations (RMSD<0.5 Å) of the triazole linkages compared to the parent disulfide molecules. The triazole-bridged peptides also displayed superior half-lives in liver S9 stability assays compared to disulfide-bridged peptides. This work establishes a foundation for the application of 1,5-disubstituted 1,2,3-triazoles as disulfide mimetics.

PubMed: 32270580
DOI: 10.1002/anie.202003435

実験手法

SOLUTION NMR